ResearcherNagoya UniversityNo recent work listed
Nobutake Tanaka
Matched on ORCID iD 0000-0002-2519-1494; OpenAlex author ID A5035016570. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 3 papers
Papers 7
- Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishment of planned staging laparoscopy criteri… Co-author DOI 10.1002/jhbp.1373↗
- Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment and Curative Surgical Resection. Co-author DOI 10.1080/01635581.2023.2191384↗
- High Preoperative Serum D-dimer Predicts Unfavorable Survival Outcomes for Pancreatic Cancer Patients. Co-author DOI 10.21873/anticanres.16491↗
- Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation… Co-author DOI 10.1245/s10434-022-12039-5↗
- Comparison Between FOLFIRINOX and nal-IRI/FL as Second-line Treatment After Gemcitabine Plus Nab-paclitaxel for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.15882↗
- Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy. Co-author DOI 10.1186/s13148-021-01165-8↗
- Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer. Co-author DOI 10.1038/s41598-018-28253-9↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mitsuro Kanda · 7 shared papers, 2018–2023 · strength 0.93
- Paper Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishmen… DOI 10.1002/jhbp.1373↗
- Paper Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment a… DOI 10.1080/01635581.2023.2191384↗
- Paper High Preoperative Serum D-dimer Predicts Unfavorable Survival Outcomes for Pancreatic Cancer Patients. DOI 10.21873/anticanres.16491↗
- Masamichi Hayashi · 7 shared papers, 2018–2023 · strength 0.93
- Paper Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishmen… DOI 10.1002/jhbp.1373↗
- Paper Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment a… DOI 10.1080/01635581.2023.2191384↗
- Paper High Preoperative Serum D-dimer Predicts Unfavorable Survival Outcomes for Pancreatic Cancer Patients. DOI 10.21873/anticanres.16491↗
- Yasuhiro Kodera · 7 shared papers, 2018–2023 · strength 0.93
- Paper Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishmen… DOI 10.1002/jhbp.1373↗
- Paper Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment a… DOI 10.1080/01635581.2023.2191384↗
- Paper High Preoperative Serum D-dimer Predicts Unfavorable Survival Outcomes for Pancreatic Cancer Patients. DOI 10.21873/anticanres.16491↗
- Norifumi Hattori · 6 shared papers, 2018–2023 · strength 0.82
- Paper Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishmen… DOI 10.1002/jhbp.1373↗
- Paper Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment a… DOI 10.1080/01635581.2023.2191384↗
- Paper High Preoperative Serum D-dimer Predicts Unfavorable Survival Outcomes for Pancreatic Cancer Patients. DOI 10.21873/anticanres.16491↗
- Fuminori Sonohara · 3 shared papers, 2018–2022 · strength 0.30
- Paper Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motil… DOI 10.1245/s10434-022-12039-5↗
- Paper Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduoden… DOI 10.1186/s13148-021-01165-8↗
- Paper Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer. DOI 10.1038/s41598-018-28253-9↗
- Suguru Yamada · 3 shared papers, 2018–2022 · strength 0.30
- Paper Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motil… DOI 10.1245/s10434-022-12039-5↗
- Paper Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduoden… DOI 10.1186/s13148-021-01165-8↗
- Paper Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer. DOI 10.1038/s41598-018-28253-9↗
- Tomohisa Otsu · 2 shared papers, 2022–2023 · strength 0.29
- Shinji Mii · 1 shared paper, 2022 · strength 0.12
- Masaya Yamanaka · 1 shared paper, 2022 · strength 0.12
- Yuki Sunagawa · 1 shared paper, 2021 · strength 0.11
- Masaya Suenaga · 1 shared paper, 2018 · strength 0.07
- Tsutomu Fujii · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.